A Study of CTD402 in T-ALL/LBL Patients

Clinical trial NCT07070219 · RECRUITING

Trial details

NCT number: NCT07070219
Sponsor: Imviva Bio
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia Refractory Lymphoma, Lymphoblastic

Start date: 2025-10-07
Primary completion: 2028-09-30
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.